Cite Filings / AVTX / 0001628280-24-030232

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Avalo Therapeutics, Inc. Filed 2024-06-27 Acc 0001628280-24-030232

Documents 1

DEF 14A Proxy Statement , def14a2024.htm

Around this filing

2025-05-01 DEF 14A Proxy Statement
2024-06-27 ARS Annual Report to Security Holders
2024-06-27 DEFA14A Proxy Materials
2024-06-27 DEF 14A Proxy Statement
2024-06-25 4 Changes in Ownership
2024-06-25 3 Initial Statement of Ownership
2023-10-19 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading def14a2024.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…